James V. Cassella, Chief Development Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 21,164 shares at $20.18 ($427K) on 2018-04-17, disclosed to the SEC on 2018-04-19.
Open-market sale of $427k CNCE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.18 | 10,582 | $214K | 50.0% |
| 2 | $20.18 | 10,582 | $214K | 50.0% |
| Total | $20.18 avg | 21,164 | $427K | 100% |
| Filing → |
| CNCE | SELL | 2023-01-09 | $21K | — | Filing → |
| CNCE | SELL | 2022-02-16 | $12K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |